Press "Enter" to skip to content

New patent expiration for Astrazeneca Pharms drug OMNARIS

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Astrazeneca Pharms drug OMNARIS

Annual Drug Patent Expirations for OMNARIS
Annual Drug Patent Expirations for OMNARIS

Omnaris is a drug marketed by Astrazeneca Pharms and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug and one Paragraph IV challenge.

OMNARIS drug price trends.

This drug has one hundred and forty-five patent family members in forty-three countries.

The generic ingredient in OMNARIS is ciclesonide. Two suppliers are listed for this compound. Additional details are available on the ciclesonide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Astrazeneca Pharms drug OMNARIS
Do NOT follow this link or you will be banned from the site!